IL-15 immunotherapy is a viable strategy for COVID-19

Coronavirus disease 2019 (COVID-19) is a pulmonary inflammatory disease induced by a newly recognized coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 infection was detected for the first time in the city of Wuhan in China and spread all over the world at the beg...

Descripción completa

Detalles Bibliográficos
Autores principales: Kandikattu, Hemanth Kumar, Venkateshaiah, Sathisha Upparahalli, Kumar, Sandeep, Mishra, Anil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537239/
https://www.ncbi.nlm.nih.gov/pubmed/32536564
http://dx.doi.org/10.1016/j.cytogfr.2020.06.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537239/
https://www.ncbi.nlm.nih.gov/pubmed/32536564
http://dx.doi.org/10.1016/j.cytogfr.2020.06.008

Ejemplares similares